PIK3CD and glioblastoma: Therefore, rational combination with other molecule’s inhibitors or other therapeutic approaches, and discovery of more specific PI3K inhibitors or an effective drug-delivery system with BBB permeability are required to improve the therapeutic effects of PI3K inhibitors for GBM.